期刊文献+

Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein 被引量:16

Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein
原文传递
导出
摘要 Background P-glycoprotein (P-gp) encoded by ATP-binding cassette sub-family B member 1 (ABCB1) gene is a kind of ATP-dependent drug transporter, which plays important roles in multidrug resistance (MDR) of human cancers, such as osteosarcoma. Curcumin is a natural phenolic coloring compound originating from the rhizomes of Curcuma Ionga, which is proved to possess antitumor biological activities including reversion of MDR. However, the effect and molecular mechanisms of curcumin to osteosarcoma MDR remain unclear. Background P-glycoprotein (P-gp) encoded by ATP-binding cassette sub-family B member 1 (ABCB1) gene is a kind of ATP-dependent drug transporter, which plays important roles in multidrug resistance (MDR) of human cancers, such as osteosarcoma. Curcumin is a natural phenolic coloring compound originating from the rhizomes of Curcuma Ionga, which is proved to possess antitumor biological activities including reversion of MDR. However, the effect and molecular mechanisms of curcumin to osteosarcoma MDR remain unclear.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第21期4116-4123,共8页 中华医学杂志(英文版)
关键词 CURCUMIN P-GLYCOPROTEIN multidrug resistance osteosarcoma MNNG/HOS cell curcumin P-glycoprotein multidrug resistance osteosarcoma MNNG/HOS cell
  • 相关文献

参考文献4

二级参考文献25

  • 1Jian-GuoCao,xiao-QingTang,Shu-HongShi.Multidrug resistance reversal in human gastric carcinoma cells by neferine[J].World Journal of Gastroenterology,2004,10(20):3062-3064. 被引量:18
  • 2Vogelzang NJ, Stadler WM. Kidney cancer. Lancet 1998; 352: 1691-1696.
  • 3Motzer RJ, Russo E Systemic therapy for renal cell carcinoma. J Urol 2000; 163: 408-417.
  • 4Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression ofa multidrug- resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A 1987; 84: 265-269.
  • 5Baird RD, Kaye SB. Drug resistance reversal - are we getting closer? Eur J Cancer 2003; 39: 2450-2461.
  • 6Wu L, Smythe AM, Stinson SF, Mullendore LA, Monks A, Scudiero DA, et al. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res 1992; 52: 3029-3034.
  • 7Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, et al. Generation of a drug resistance profile by quantitation of MDR-1/P-glycoprotein in the cell lines of the National Cancer Institute anticancer drug screen. J Clin Invest 1995; 95: 2205-2214.
  • 8Mickisch GH, K6ssig J, Keilhauer G, Schlick E, Tschada RK, Alken PM. Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas. Cancer Res 1990; 50: 3670-3674.
  • 9Mickisch GH, Roehrich K, Koessig J, Forster S, Tschada RK, Alken PM. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. J Urol 1990; 144: 755-759.
  • 10Lehnert M. Multidrug resistance in human cancer. J Neurooncol 1994; 22: 239-243.

共引文献64

同被引文献171

引证文献16

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部